Enovis Corporation logo

Enovis Corporation (ENOV) Financials

NYSE NYSE:ENOV

Market Cap

2.96B

Total Revenue

1.56B

Gross Profit

869.38M

Operating Income

-88.57M

Net Income

-38.19M

Metric2013201420152016201720182019202020212022
4,207,209,0004,624,476,0003,967,053,0003,647,047,0003,300,184,0003,666,812,0003,327,458,0003,070,769,0003,854,303,0001,563,101,000
2,900,987,0003,145,631,0002,715,279,0002,501,396,0002,270,709,0002,533,973,0001,926,402,0001,782,664,0002,240,645,000693,718,000
1,306,222,0001,478,845,0001,251,774,0001,145,651,0001,029,475,0001,132,839,0001,401,056,0001,288,105,0001,613,658,000869,383,000
------------------60,827,000
--------------------
--------------------
860,994,0001,011,171,000905,952,000825,240,000732,340,000818,210,0001,132,149,0001,087,401,0001,329,376,000772,913,000
860,994,0001,011,171,000905,952,000825,240,000732,340,000818,210,0001,132,149,0001,087,401,0001,329,376,000960,041,000
406,392,000409,553,000284,645,000238,015,00029,151,000236,943,000203,612,000162,291,000256,643,000-88,570,000
-38,836,000-58,121,000-61,177,000-82,396,000-267,984,000-87,775,000-153,119,000-104,262,000-91,255,00086,501,000
564,486,000642,398,000500,364,000455,443,000384,956,000456,545,000471,317,000446,933,000558,409,000131,140,000
119,258,000174,724,000154,542,000143,258,000134,754,000141,877,000267,705,000284,642,000301,766,000219,710,000
--------------------
103,597,00051,305,00047,743,00030,016,00041,137,00044,052,000119,503,000104,262,00072,593,00024,052,000
302,795,000358,248,000236,902,000207,999,000-11,986,000182,802,00050,493,00058,029,000165,388,000-2,069,000
93,652,000-62,025,00049,724,00062,808,00042,554,000-21,00031,630,000-6,053,00066,695,00036,120,000
178,628,000392,098,000167,739,000128,111,000151,090,000140,196,00018,863,00064,082,00098,693,000-38,189,000
4.689.184.053.123.693.480.421.411.93-0.71
4.629.064.023.123.663.480.421.411.93-0.71
33,810,22340,325,12341,416,99641,061,17740,945,75940,286,16745,213,83745,588,70851,141,21054,030,899
33,810,22341,344,62541,623,17441,066,29241,331,95840,286,16745,213,83745,588,70851,141,21054,030,899
3,761,981,0004,156,802,0003,621,231,0003,326,636,0003,003,049,0003,352,183,0003,058,551,0002,870,065,0003,570,021,0001,653,759,000
-------8,226,000-46,933,00039,000-33,616,000--11,208,000126,301,000

Key Facts

Industry

Specialty Industrial Machinery

Sector

Industrials

Headquarters

Wilmington, DE, US

Website

enovis.com

CEO

Mr. Matthew L. Trerotola

Employees

6800

About the Company

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.